Do analysts recommend OPTH or MIST?

Milestone Pharmaceuticals has a consensus price target of $6.40, suggesting a potential upside of 597.32%. Given Milestone Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Milestone Pharmaceuticals is more favorable than Optimi Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Optimi Health 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Milestone Pharmaceuticals 1 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.71

Is OPTH or MIST more profitable?

Optimi Health's return on equity of 0.00% beat Milestone Pharmaceuticals' return on equity. Company Net Margins Return on Equity Return on Assets Optimi Health N/A N/A N/A Milestone Pharmaceuticals N/A -288.33% -58.27%

Does the media prefer OPTH or MIST?

In the previous week, Optimi Health had 1 more articles in the media than Milestone Pharmaceuticals. MarketBeat recorded 3 mentions for Optimi Health and 2 mentions for Milestone Pharmaceuticals. Optimi Health's average media sentiment score of 0.39 beat Milestone Pharmaceuticals' score of 0.00 indicating that Optimi Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Optimi Health 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Milestone Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate VANI or OPTH?

Vivani Medical presently has a consensus price target of $3.75, indicating a potential upside of 202.42%. Given Vivani Medical's stronger consensus rating and higher probable upside, analysts plainly believe Vivani Medical is more favorable than Optimi Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vivani Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25 Optimi Health 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is VANI or OPTH more profitable?

Optimi Health's return on equity of 0.00% beat Vivani Medical's return on equity. Company Net Margins Return on Equity Return on Assets Vivani Medical N/A -191.05% -70.91% Optimi Health N/A N/A N/A

Does the media refer more to VANI or OPTH?

In the previous week, Optimi Health had 2 more articles in the media than Vivani Medical. MarketBeat recorded 3 mentions for Optimi Health and 1 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 1.05 beat Optimi Health's score of 0.39 indicating that Vivani Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Vivani Medical 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Optimi Health 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend OPTH or RFL?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Optimi Health 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Rafael 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Is OPTH or RFL more profitable?

Optimi Health has a net margin of 0.00% compared to Rafael's net margin of -3,321.74%. Optimi Health's return on equity of 0.00% beat Rafael's return on equity. Company Net Margins Return on Equity Return on Assets Optimi Health N/A N/A N/A Rafael -3,321.74% -41.27% -35.32%

Does the media prefer OPTH or RFL?

In the previous week, Optimi Health had 2 more articles in the media than Rafael. MarketBeat recorded 3 mentions for Optimi Health and 1 mentions for Rafael. Optimi Health's average media sentiment score of 0.39 beat Rafael's score of 0.00 indicating that Optimi Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Optimi Health 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Rafael 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts recommend OPTH or CPIX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Optimi Health 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50 Cumberland Pharmaceuticals 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer OPTH or CPIX?

In the previous week, Optimi Health had 1 more articles in the media than Cumberland Pharmaceuticals. MarketBeat recorded 3 mentions for Optimi Health and 2 mentions for Cumberland Pharmaceuticals. Optimi Health's average media sentiment score of 0.39 beat Cumberland Pharmaceuticals' score of 0.25 indicating that Optimi Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Optimi Health 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Cumberland Pharmaceuticals 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate PLYX or OPTH?

Polaryx Therapeutics currently has a consensus target price of $7.67, suggesting a potential upside of 258.26%. Given Polaryx Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Polaryx Therapeutics is more favorable than Optimi Health. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Polaryx Therapeutics 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 2.60 Optimi Health 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Is PLYX or OPTH more profitable?

Company Net Margins Return on Equity Return on Assets Polaryx Therapeutics N/A N/A N/A Optimi Health N/A N/A N/A

Optimi Health (OPTH) Competitors

$4.84 -0.11 (-2.22%)

As of 04:00 PM Eastern

Compare

OPTH vs. MIST, VANI, RFL, CPIX, and PLYX

Should you buy Optimi Health stock or one of its competitors? Optimi Health's main competitors and comparable companies include Milestone Pharmaceuticals (MIST), Vivani Medical (VANI), Rafael (RFL), Cumberland Pharmaceuticals (CPIX), and Polaryx Therapeutics (PLYX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Optimi Health compare to Milestone Pharmaceuticals?

Optimi Health (NASDAQ:OPTH) and Milestone Pharmaceuticals (NASDAQ:MIST) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk.

86.2% of Milestone Pharmaceuticals shares are owned by institutional investors. 5.0% of Milestone Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Optimi Health's return on equity of 0.00% beat Milestone Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Optimi Health	N/A	N/A	N/A
Milestone Pharmaceuticals	N/A	-288.33%	-58.27%

In the previous week, Optimi Health had 1 more articles in the media than Milestone Pharmaceuticals. MarketBeat recorded 3 mentions for Optimi Health and 2 mentions for Milestone Pharmaceuticals. Optimi Health's average media sentiment score of 0.39 beat Milestone Pharmaceuticals' score of 0.00 indicating that Optimi Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Optimi Health	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Milestone Pharmaceuticals	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Optimi Health has higher earnings, but lower revenue than Milestone Pharmaceuticals. Optimi Health is trading at a lower price-to-earnings ratio than Milestone Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Optimi Health	$310K	89.46	-$1.12M	-$0.76	N/A
Milestone Pharmaceuticals	$1.55M	73.72	-$63.06M	-$0.69	N/A

Milestone Pharmaceuticals has a consensus price target of $6.40, suggesting a potential upside of 597.32%. Given Milestone Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Milestone Pharmaceuticals is more favorable than Optimi Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Optimi Health	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Milestone Pharmaceuticals	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71

Summary

Milestone Pharmaceuticals beats Optimi Health on 9 of the 15 factors compared between the two stocks.

How does Optimi Health compare to Vivani Medical?

Vivani Medical (NASDAQ:VANI) and Optimi Health (NASDAQ:OPTH) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, media sentiment, analyst recommendations, valuation, risk and institutional ownership.

6.8% of Vivani Medical shares are owned by institutional investors. 53.3% of Vivani Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Optimi Health's return on equity of 0.00% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-191.05%	-70.91%
Optimi Health	N/A	N/A	N/A

Optimi Health has higher revenue and earnings than Vivani Medical. Optimi Health is trading at a lower price-to-earnings ratio than Vivani Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.35	N/A
Optimi Health	$310K	89.46	-$1.12M	-$0.76	N/A

Vivani Medical presently has a consensus price target of $3.75, indicating a potential upside of 202.42%. Given Vivani Medical's stronger consensus rating and higher probable upside, analysts plainly believe Vivani Medical is more favorable than Optimi Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Optimi Health	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

In the previous week, Optimi Health had 2 more articles in the media than Vivani Medical. MarketBeat recorded 3 mentions for Optimi Health and 1 mentions for Vivani Medical. Vivani Medical's average media sentiment score of 1.05 beat Optimi Health's score of 0.39 indicating that Vivani Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vivani Medical	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Optimi Health	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Vivani Medical beats Optimi Health on 8 of the 13 factors compared between the two stocks.

How does Optimi Health compare to Rafael?

Optimi Health (NASDAQ:OPTH) and Rafael (NYSE:RFL) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, earnings, institutional ownership, valuation, dividends, profitability and media sentiment.

In the previous week, Optimi Health had 2 more articles in the media than Rafael. MarketBeat recorded 3 mentions for Optimi Health and 1 mentions for Rafael. Optimi Health's average media sentiment score of 0.39 beat Rafael's score of 0.00 indicating that Optimi Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Optimi Health	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Rafael	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Optimi Health	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Rafael	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Optimi Health has a net margin of 0.00% compared to Rafael's net margin of -3,321.74%. Optimi Health's return on equity of 0.00% beat Rafael's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Optimi Health	N/A	N/A	N/A
Rafael	-3,321.74%	-41.27%	-35.32%

Optimi Health has higher earnings, but lower revenue than Rafael. Optimi Health is trading at a lower price-to-earnings ratio than Rafael, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Optimi Health	$310K	89.46	-$1.12M	-$0.76	N/A
Rafael	$920K	111.91	-$30.52M	-$0.68	N/A

11.3% of Rafael shares are held by institutional investors. 32.9% of Rafael shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Summary

Optimi Health beats Rafael on 7 of the 13 factors compared between the two stocks.

How does Optimi Health compare to Cumberland Pharmaceuticals?

Optimi Health (NASDAQ:OPTH) and Cumberland Pharmaceuticals (NASDAQ:CPIX) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, valuation, analyst recommendations, media sentiment, risk, dividends, profitability and institutional ownership.

15.5% of Cumberland Pharmaceuticals shares are held by institutional investors. 42.1% of Cumberland Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Optimi Health has higher earnings, but lower revenue than Cumberland Pharmaceuticals. Cumberland Pharmaceuticals is trading at a lower price-to-earnings ratio than Optimi Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Optimi Health	$310K	89.46	-$1.12M	-$0.76	N/A
Cumberland Pharmaceuticals	$44.52M	2.55	-$2.84M	-$0.71	N/A

Optimi Health has a net margin of 0.00% compared to Cumberland Pharmaceuticals' net margin of -34.40%. Optimi Health's return on equity of 0.00% beat Cumberland Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Optimi Health	N/A	N/A	N/A
Cumberland Pharmaceuticals	-34.40%	-28.81%	-9.25%

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Optimi Health	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50
Cumberland Pharmaceuticals	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Optimi Health had 1 more articles in the media than Cumberland Pharmaceuticals. MarketBeat recorded 3 mentions for Optimi Health and 2 mentions for Cumberland Pharmaceuticals. Optimi Health's average media sentiment score of 0.39 beat Cumberland Pharmaceuticals' score of 0.25 indicating that Optimi Health is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Optimi Health	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cumberland Pharmaceuticals	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Optimi Health beats Cumberland Pharmaceuticals on 9 of the 13 factors compared between the two stocks.

How does Optimi Health compare to Polaryx Therapeutics?

Polaryx Therapeutics (NASDAQ:PLYX) and Optimi Health (NASDAQ:OPTH) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

In the previous week, Optimi Health had 3 more articles in the media than Polaryx Therapeutics. MarketBeat recorded 3 mentions for Optimi Health and 0 mentions for Polaryx Therapeutics. Optimi Health's average media sentiment score of 0.39 beat Polaryx Therapeutics' score of 0.00 indicating that Optimi Health is being referred to more favorably in the news media.

Company	Overall Sentiment
Polaryx Therapeutics	Neutral
Optimi Health	Neutral

Polaryx Therapeutics currently has a consensus target price of $7.67, suggesting a potential upside of 258.26%. Given Polaryx Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Polaryx Therapeutics is more favorable than Optimi Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Polaryx Therapeutics	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Optimi Health	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Optimi Health has higher revenue and earnings than Polaryx Therapeutics. Polaryx Therapeutics is trading at a lower price-to-earnings ratio than Optimi Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Polaryx Therapeutics	N/A	N/A	-$8.98M	-$0.08	N/A
Optimi Health	$310K	89.46	-$1.12M	-$0.76	N/A

Company	Net Margins	Return on Equity	Return on Assets
Polaryx Therapeutics	N/A	N/A	N/A
Optimi Health	N/A	N/A	N/A

Summary

Polaryx Therapeutics and Optimi Health tied by winning 5 of the 10 factors compared between the two stocks.

Get Optimi Health News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OPTH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

OPTH vs. The Competition

Export

Metric	Optimi Health	Pharmaceuticals Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$28.34M	$12.53B	$7.26B	$12.97B
Dividend Yield	N/A	2.64%	2.53%	12.80%
P/E Ratio	-6.37	789.79	274.69	25.77
Price / Sales	89.46	753.32	647.76	90.39
Price / Cash	N/A	15.08	28.04	34.72
Price / Book	N/A	10.57	10.56	6.36
Net Income	-$1.12M	$2.82B	$3.49B	$358.17M
7 Day Performance	1.68%	-0.36%	-0.23%	0.54%
1 Month Performance	-3.20%	-1.19%	-2.80%	-2.95%
1 Year Performance	N/A	4.01%	18.25%	6.08%

Optimi Health Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
OPTH Optimi Health	0.8906 of 5 stars	$4.84 -2.2%	N/A	N/A	$28.34M	$310K	N/A	9
MIST Milestone Pharmaceuticals	1.8255 of 5 stars	$0.92 +3.4%	$6.40 +596.0%	-52.3%	$110.70M	$1.55M	N/A	38	News Coverage
VANI Vivani Medical	3.4159 of 5 stars	$1.21 -0.8%	$3.75 +209.9%	-15.6%	$110.05M	N/A	N/A	36	Positive News
RFL Rafael	0.1289 of 5 stars	$2.08 +1.2%	N/A	+44.9%	$107.12M	$920K	N/A	23	Gap Up
CPIX Cumberland Pharmaceuticals	0.8232 of 5 stars	$7.19 +3.0%	N/A	+132.4%	$104.58M	$44.52M	N/A	93

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:OPTH) was last updated on 9/21/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Optimi Health (OPTH) Competitors

OPTH vs. MIST, VANI, RFL, CPIX, and PLYX

How does Optimi Health compare to Milestone Pharmaceuticals?

Summary

How does Optimi Health compare to Vivani Medical?

Summary

How does Optimi Health compare to Rafael?

Summary

How does Optimi Health compare to Cumberland Pharmaceuticals?

Summary

How does Optimi Health compare to Polaryx Therapeutics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OPTH vs. The Competition

Optimi Health Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Optimi Health (OPTH) Competitors

OPTH vs. MIST, VANI, RFL, CPIX, and PLYX

How does Optimi Health compare to Milestone Pharmaceuticals?

Do insiders and institutionals hold more shares of OPTH or MIST?

Is OPTH or MIST more profitable?

Does the media prefer OPTH or MIST?

Which has better valuation & earnings, OPTH or MIST?

Do analysts recommend OPTH or MIST?

Summary

How does Optimi Health compare to Vivani Medical?

Do institutionals & insiders believe in VANI or OPTH?

Is VANI or OPTH more profitable?

Which has stronger valuation & earnings, VANI or OPTH?

Do analysts rate VANI or OPTH?

Does the media refer more to VANI or OPTH?

Summary

How does Optimi Health compare to Rafael?

Does the media prefer OPTH or RFL?

Do analysts recommend OPTH or RFL?

Is OPTH or RFL more profitable?

Which has preferable valuation & earnings, OPTH or RFL?

Do insiders and institutionals believe in OPTH or RFL?

Summary

How does Optimi Health compare to Cumberland Pharmaceuticals?

Do institutionals and insiders have more ownership in OPTH or CPIX?

Which has preferable earnings & valuation, OPTH or CPIX?

Is OPTH or CPIX more profitable?

Do analysts recommend OPTH or CPIX?

Does the media prefer OPTH or CPIX?

Summary

How does Optimi Health compare to Polaryx Therapeutics?

Does the media favor PLYX or OPTH?

Do analysts rate PLYX or OPTH?

Which has higher valuation and earnings, PLYX or OPTH?

Is PLYX or OPTH more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

OPTH vs. The Competition

Optimi Health Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools